Diskin B, Adam S, Soto GS, Liria M, et al. BTLA(+)CD200(+) B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer. Oncogene 2022;41:4349-4360.
PMID: 35948648